Oregon Health & Science University at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Oregon Health & Science University brings 7 presentations to ObesityWeek 2026 in National Harbor. Its sessions cover where obesity medicine and bariatric surgery are heading, including the past year's approvals and regulatory updates. They include an essential amino acid supplement that improves muscle and liver composition after surgical weight loss.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Oregon Health & Science University Portland, OR | |
Public academic health center in Portland, Oregon. | Poster Sat Nov 14 7:30pm–8:30pm Essential Amino Acid Supplement Improves Muscle and Hepatic Composition After Surgical Weight Loss Metabolism and integrative physiology Session Sun Nov 15 9:30am–10:30am Session Sun Nov 15 12:00pm–1:00pm TOS Bariatric Surgery and Devices Section Meeting (TOS members only) Members-only lunch on caring for patients with very high BMI, from medical weight management to surgery, ending with the section's two top abstracts. Bariatric surgery and devices Session Sun Nov 15 1:30pm–2:30pm TOS Awards Plenary: Perspectives on Obesity: Science, Behavior, and the Path Forward Obesity researchers honored with society awards reflect on how thinking about obesity shifted, discuss lasting misconceptions, and offer advice to newcomers. Interventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPolicy and public health Talk Mon Nov 16 9:00am–9:15am The Future of Obesity Medicine and Metabolic and Bariatric Surgery Clinical obesity care and professional practiceObesity pharmacotherapy and drug developmentBariatric surgery and devices Poster Mon Nov 16 2:30pm–3:30pm Outcomes of a Weight Management Program Embedded in a Pediatric Primary Care Clinic Pediatric and adolescent obesityObesity pharmacotherapy and drug development Session Mon Nov 16 3:30pm–4:30pm The Year in Obesity Approvals and Regulatory Updates FDA staff review the past year's obesity drug approvals, label changes and safety notices, and preview regulatory and scientific issues ahead. Population health and epidemiologyClinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesity |
Find decision makers at Oregon Health & Science University
Tell us what you sell and we’ll find the people at Oregon Health & Science University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction